ribavirin has been researched along with Acute Hemolytic Transfusion Reaction in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 10 (58.82) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Husic-Selimovic, A; Jahic, E; Merhemic, Z; Prohic, D; Sofic, A | 1 |
| Belleli, D; Davis, AK; Kemp, W; McCarthy, P; Northcott, MJ; Ong, WL; Street, A; Tran, H; Walsh, M | 1 |
| Allen, TM; Park, SH; Rehermann, B; Tully, DC; Veerapu, NS | 1 |
| Mallat, ME; Sharara, AI | 1 |
| Kalpaka, A; Klonizakis, P; Paschos, P; Pasvanti, C; Perifanis, V; Sinakos, E; Vlachaki, E | 1 |
| Cheng, ML; Liu, SD; Ren, H; Shu, DY; Yang, QK | 1 |
| Benhamou, Y; Bernard, B; Di Martino, V; Moussalli, J; Myers, RP; Poynard, T; Ratziu, V; Regimbeau, C; Thabut, D | 1 |
| Banks, A; Castro, O; Giday, S; Hasan, S; Hassan, M; Smoot, D | 1 |
| Kawamura, A; Kukita, K; Saitou, M; Tuyuguchi, M | 1 |
| Iitsuka, T; Kanzaki, S; Murakami, J; Nagata, I; Okamoto, M; Shiraki, K | 1 |
| Butensky, E; Foote, D; Harmatz, P; Pakbaz, Z; Vichinsky, EP; Walters, MC | 1 |
| Bricaire, F | 1 |
| Champlin, RE; Englund, J; Ghosh, S; Giralt, SA; Ippoliti, C; Jacobson, K; Mallik, S; Neumann, J; Raad, I; Rolston, K; Whimbey, E | 1 |
| Lauer, GM; Walker, BD | 1 |
| Elkabes, B; Saner, G; Sökücü, S; Süoğlu D, OD | 1 |
| Chan, PK; Ha, SY; Li, CK; Ling, SC | 1 |
7 review(s) available for ribavirin and Acute Hemolytic Transfusion Reaction
| Article | Year |
|---|---|
Treatment and prevention of hepatitis B and C in thalassemia.
Topics: Antiviral Agents; Hemolysis; Hepatitis B; Hepatitis C; Humans; Ribavirin; Thalassemia; Transfusion Reaction | 2009 |
[What are the indications for treatment of acute hepatitis C?].
Topics: Acute Disease; Adult; Antiviral Agents; Clinical Enzyme Tests; Clinical Trials as Topic; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Interferon alpha-2; Interferon-alpha; Interferon-beta; Male; Meta-Analysis as Topic; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Risk Factors; Substance-Related Disorders; Time Factors; Transaminases; Transfusion Reaction | 2002 |
HCV in sickle cell disease.
Topics: Anemia, Sickle Cell; Antiviral Agents; Chronic Disease; Comorbidity; Disease Progression; Genotype; Hepacivirus; Hepatitis C; Humans; Interferons; Liver; Prevalence; Ribavirin; Transfusion Reaction; United States | 2003 |
[Prevalence of hepatitis C virus infection among chronic hemodialysis patients].
Topics: Antiviral Agents; Biomarkers; Chronic Disease; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Interferon-alpha; Prevalence; Renal Dialysis; Ribavirin; Risk; RNA, Viral; Time Factors; Transfusion Reaction | 2004 |
[Hepatitis C in childhood--natural history and therapy].
Topics: Adolescent; Antiviral Agents; Biomarkers; Child; Child, Preschool; Disease Transmission, Infectious; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Infant; Infant, Newborn; Interferons; Liver; Mother-Child Relations; Prognosis; Ribavirin; RNA, Viral; Transfusion Reaction | 2004 |
Hepatitis C. Shedding light on the shadow epidemic.
Topics: Hepatitis C; Humans; Interferons; Ribavirin; Substance Abuse, Intravenous; Transfusion Reaction; United States | 1999 |
Hepatitis C virus infection.
Topics: Antiviral Agents; Disease Progression; Drug Therapy, Combination; Genome, Viral; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Liver; Liver Transplantation; Prevalence; Ribavirin; Transfusion Reaction | 2001 |
5 trial(s) available for ribavirin and Acute Hemolytic Transfusion Reaction
| Article | Year |
|---|---|
Safety and efficacy of combination therapy with pegylated interferon alpha-2a and ribavirin in treating patients with chronic hepatitis C and beta-thalassaemia major: a Greek single-center experience.
Topics: Adult; Antiviral Agents; beta-Thalassemia; Chelation Therapy; Drug Therapy, Combination; Female; Greece; Hepatitis C, Chronic; Homozygote; Humans; Interferon alpha-2; Interferon-alpha; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Transfusion Reaction; Treatment Outcome | 2011 |
[Effect of interferon and ribavirin combination therapy in sixty-two patients with chronic hepatitis C originating from a single blood donor].
Topics: Adolescent; Adult; Antiviral Agents; Blood Donors; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral; Transfusion Reaction; Treatment Outcome; Viral Load; Young Adult | 2012 |
Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.
Topics: Adult; Aerosols; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Pilot Projects; Pneumonia, Viral; Postoperative Complications; Respiratory Syncytial Virus Infections; Ribavirin; Transfusion Reaction; Transplantation, Autologous; Transplantation, Homologous | 2000 |
Does interferon and ribavirin combination therapy increase the rate of treatment response in children with hepatitis C?
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Infant; Interferon-alpha; Male; Ribavirin; Transfusion Reaction; Treatment Outcome; Viral Load | 2002 |
Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major.
Topics: Adolescent; Adult; Antiviral Agents; beta-Thalassemia; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Ribavirin; Transfusion Reaction | 2002 |
5 other study(ies) available for ribavirin and Acute Hemolytic Transfusion Reaction
| Article | Year |
|---|---|
Impact of Different Sources of Infection on Therapy Response in Chronic Hepatitis C.
Topics: Adult; Antiviral Agents; Blood Transfusion; Bosnia and Herzegovina; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Iatrogenic Disease; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Transfusion Reaction; Treatment Outcome | 2018 |
Prevalence of transfusion-acquired hepatitis C in an Australian bleeding disorders population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Australia; Blood Coagulation Disorders; Blood Transfusion; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C Antibodies; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Retrospective Studies; Ribavirin; Transfusion Reaction; Young Adult | 2013 |
Trace amounts of sporadically reappearing HCV RNA can cause infection.
Topics: Animals; Antiviral Agents; Genetic Variation; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Pan troglodytes; Phylogeny; Plasma; Ribavirin; RNA, Viral; T-Lymphocytes; Time Factors; Transfusion Reaction; Viremia | 2014 |
Treatment of hepatitis C virus infection in thalassemia.
Topics: Adolescent; Adult; Antiviral Agents; Biopsy, Needle; Bone Marrow Transplantation; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Iron; Iron Overload; Liver; Magnetic Resonance Imaging; Male; Mass Spectrometry; Polyethylene Glycols; Ribavirin; Thalassemia; Transfusion Reaction; Treatment Outcome; Viremia | 2005 |
[Infectious diseases in 1998].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-HIV Agents; Antiviral Agents; Bacterial Vaccines; Blood Donors; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Interferons; Lamivudine; Middle Aged; Multicenter Studies as Topic; Pneumonia, Pneumococcal; Randomized Controlled Trials as Topic; Ribavirin; Streptococcus pneumoniae; Transfusion Reaction; Zidovudine | 1999 |